Clinical Trials in Illinois

Showing 9341-9360 of 14,943 trials

Design Validation of Senofilcon A With New UV-blocking Additive

NCT03707821

This is a 2-visit, multi-site, partially subject-masked, 2-arm parallel, controlled, randomized and dispensing trial. Subjects will be randomized to one of two study lenses for the entire duration of the study. The study lenses will be worn for a period of 2 weeks each in a bilateral fashion.

Visual Acuity

Johnson & Johnson Vision Care, Inc.253 participantsStarted Oct 2018

Cupertino, California, United States • Maitland, Florida, United States • Tallahassee, Florida, United States +7 more locations

COMPLETEDPhase 3113 miles

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

NCT02065791

The goal of this study is to assess whether canagliflozin has a renal and vascular protective effect in reducing the progression of renal impairment relative to placebo in participants with type 2 diabetes mellitus (T2DM), Stage 2 or 3 chronic kidney disease (CKD) and macroalbuminuria, who are receiving standard of care including a maximum tolerated labeled daily dose of an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB).

Diabetes Mellitus, Type 2Diabetic Nephropathy

Janssen Research & Development, LLC4,401 participantsStarted Feb 2014

Birmingham, Alabama, United States • Montgomery, Alabama, United States • Tempe, Arizona, United States +572 more locations

Design Validation of Senofilcon A With New UV-blocking Additive

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

Find Trials by Condition in Illinois

Post Market Surveillance Study of the Wingspan Stent System

HW006 LATERAL Thoracotomy

Safety and Efficacy of PRP for Treatment of Disc Pain

PF-06741086 Multiple Dose Study in Severe Hemophilia

Safety and Efficacy Study of Sebelipase Alfa in Participants With Lysosomal Acid Lipase Deficiency

ImageReady(TM) MR Conditional Pacing System Clinical Study

Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis

Novel Mobile Device Application to Improve Adherence

Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine

A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects

A Clinical Trial of IntensiVE Dialysis

Incentivized Smoking Cessation for Diabetics

E-training of Inmate Peer Caregivers for Enhancing Geriatric and End-of-life Care in Prisons

Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC

Study of the Cabochon System for Improvement in the Appearance of Cellulite

Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis

Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues